Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Game-Changing Stock Has Catalysts Ahead

Page 1 of 2

Over the past year, as we’ve grown more accustomed to simply speaking requests into our smartphones, we’ve started typing less and less.

It’s a subtle shift right now, but in coming years, futurists predict we’ll be dictating our emails, tweets, text messages and documents, as punching letters into a keyboard becomes a slowly dying art.

Yet the company that is leading this revolution, Nuance Communications Inc. (NASDAQ:NUAN), has had little to cheer about lately. Its shares have been flat for the past two years, even as the S&P 500 index has risen 50%. The fact that activist investor Carl Icahn has bought more than 30 million shares this year and currently owns 16.9% of the company still wasn’t enough to boost the stock meaningfully higher.

Yet in the quarters ahead, there are several catalysts in place that could push this stock back toward the $30 mark. First, a quick recap of Nuance’s current woes.

Signs Of A Slowdown
Nuance posted very impressive annual results for the fiscal year that ended September 2012. Sales, earnings per share (EPS), net income and cash flow all grew more than 25%, indicating that the company’s speech recognition technology was seeing strong demand. Yet it was also apparent that key end markets were slowing, when fiscal fourth-quarter results were released last November.

Sales in the health care segment, for example, came in at $190 million in the quarter, which slightly trailed consensus forecasts. Government sales also began to slow ahead of the sequester, and in the consumer dictation segment, revenues were hurt by a shift away from upfront software purchases and toward monthly licensing fees.

Those trends have continued to play out, and fiscal 2013 sales are expected to grow just 12% to 13%, to about $1.96 billion. That’s quite a letdown for a company that had a 32% annual growth rate going back to fiscal 2005 (though some of that growth was juiced by acquisitions). Worse still, analysts expect sales to grow just 6% in the fiscal year that begins in October.

Icahn’s Presence — And Plans?
News that Icahn began building a big stake in the company may not have been seen as a welcome sign from management. After all, he’s known for ratcheting up a severe amount of pressure on underperforming management teams, compelling them to make short-term shareholder-friendly moves at the expense of long-term value creation.

Management has already identified a long-term plan, which was articulated at an annual analysts’ day last December. The plan was to boost the sales force from 675 to 775 and to devote more resources toward new product development. Those spending efforts partially explain why per-share profits are on track to fall more than 20% in fiscal 2013 (to around $1.30) and rise less than 10% in fiscal 2014.

Thus far, Icahn has not publicly disclosed any tangible steps he thinks management should be taking, but we can get a pretty good sense of what he will suggest when he starts to bang the drums more loudly. (In years past, Icahn has tended to take a big stake, remain quiet for a stretch, and then become vocal.)

Back in 2008, Icahn owned a large stake in Motorola, and eventually pressured that firm to split itself up. Motorola had a pair of key assets: a growing presence in mobile communications and a vast trove of patents. Nuance, too, has a strong mobile presence — it runs the technology behind Apple Inc. (NASDAQ:AAPL) Siri — and also owns more than 2,800 patents.

Staying The Course?
In the absence of any value-unlocking moves being pushed by Icahn or others, what’s the outlook for Nuance and speech recognition? The company’s recent sales slowdown has led some to conclude that the technology is not a true game-changer and has already made its deepest inroads into technology. They suggest that touch-screens may be enough to satisfy most data input requirements. And there have also been some concerns about speech recognition accuracy, which is obviously a key consideration for health care IT buyers.

© 2013 Nuance Communications
Nuance’s recent sales slowdown has led some to conclude that its speech recognition technology is not a true game-changer and has already made its deepest inroads into technology.
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!